Citation 86335

CHEN,JJ: CHANG,YL: TENG,CM: LIN,WY: CHEN,YC: CHEN,JS:. (2001). A NEW TETRAHYDROPROTOBERBINE N-OXIDE ALKALOID AND ANTI-PLATELET AGGREGATION CONSTITUENTS OF CORYDALIS TASHIROI.. 67(5)

Citation Details

Title	A NEW TETRAHYDROPROTOBERBINE N-OXIDE ALKALOID AND ANTI-PLATELET AGGREGATION CONSTITUENTS OF CORYDALIS TASHIROI.
Authors	CHEN,JJ: CHANG,YL: TENG,CM: LIN,WY: CHEN,YC: CHEN,JS:
Year	2001
Volume	67
Issue	5

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,CIS: (-):	ACTIVE
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,CIS: (-):	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,CIS: (-):	ACTIVE
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,CIS: (-):	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE,EPI:	ACTIVE
6	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE,EPI:	ACTIVE
7	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE,EPI:	ACTIVE
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE,EPI:	ACTIVE
9	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,TRANS: (-):	ACTIVE
10	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,TRANS: (-):	ACTIVE
11	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,TRANS: (-):	ACTIVE
12	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE-N-OXIDE,TRANS: (-):	ACTIVE
13	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE	ACTIVE
14	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE	ACTIVE
15	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE	ACTIVE
16	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYNOXIDINE	ACTIVE
17	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,TRANS-ISO: (-):	ACTIVE
18	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,TRANS-ISO: (-):	ACTIVE
19	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,TRANS-ISO: (-):	ACTIVE
20	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,TRANS-ISO: (-):	ACTIVE
21	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOULERINE	ACTIVE
22	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOULERINE	ACTIVE
23	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOULERINE	ACTIVE
24	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOULERINE	ACTIVE
25	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOPINE	ACTIVE
26	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOPINE	ACTIVE
27	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOPINE	ACTIVE
28	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOPINE	ACTIVE
29	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,OXY:	ACTIVE
30	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,OXY:	ACTIVE
31	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,OXY:	ACTIVE
32	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,OXY:	ACTIVE
33	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE	ACTIVE
34	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE	ACTIVE
35	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE	ACTIVE
36	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYDALMINE	ACTIVE
37	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO:	ACTIVE
38	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO:	ACTIVE
39	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO:	ACTIVE
40	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO:	ACTIVE
41	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,NOR:	ACTIVE
42	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,NOR:	ACTIVE
43	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,NOR:	ACTIVE
44	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,NOR:	ACTIVE
45	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE,TETRAHYDRO:	INACTIVE
46	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE,TETRAHYDRO:	ACTIVE
47	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE,TETRAHYDRO:	ACTIVE
48	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE,TETRAHYDRO:	ACTIVE
49	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE	ACTIVE
50	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE	ACTIVE
51	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE	ACTIVE
52	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMATINE	ACTIVE

Corydalis tashiroi (PAPAVERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CORYPALMINE-N-OXIDE,CIS-ISO: (-):	None
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,CIS-ISO: (-):	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,CIS-ISO: (-):	ACTIVE
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,CIS-ISO: (-):	ACTIVE
5	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CORYPALMINE-N-OXIDE,CIS-ISO: (-):	ACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SANGUINARINE,DIHYDRO: 6-METHOXY:	None
7	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO: 6-METHOXY:	ACTIVE
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO: 6-METHOXY:	ACTIVE
9	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO: 6-METHOXY:	ACTIVE
10	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGUINARINE,DIHYDRO: 6-METHOXY:	ACTIVE
11	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	JUZIPHINE,NOR:	None
12	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUZIPHINE,NOR:	ACTIVE
13	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUZIPHINE,NOR:	ACTIVE
14	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUZIPHINE,NOR:	ACTIVE
15	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUZIPHINE,NOR:	ACTIVE